Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 1.392
+0.124 (9.78%)
Aug 10, 2026, 4:00 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €139.3 million as of August 11, 2026. Its market cap has decreased by -42.41% in one year.
Market Cap
139.30M
Enterprise Value
101.50M
Revenue
21.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.39
ChartMarket Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 139.30M, a decrease of -66.66%. That is a compound annual growth rate of -17.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 139.30M | -20.74% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.73B |
| UCB SA | 42.54B |
| Financière de Tubize | 8.48B |
| Fagron NV | 1.65B |
| Ion Beam Applications | 472.98M |
| Onward Medical | 165.48M |
| Hyloris Pharmaceuticals | 127.68M |
| Sequana Medical NV | 43.56M |